22nd week of 2015 patent applcation highlights part 50 |
Patent application number | Title | Published |
20150148506 | SYSTEM AND METHOD FOR RAPID TRANSITIONING OF POLYOLEFIN PROCESSES FROM ONE PRODUCT TO ANOTHER - A gas-phase polyolefin reactor system for rapidly transitioning from one polyolefin product to another is disclosed. The reactor system comprises a control valve, a high-flow valve, a polyolefin reactor, a flow meter, a totalizer and an empirical model. During a transition, the empirical model predicts a required amount based upon an initial concentration and a selected ending concentration, the flow meter measures a flow rate, the totalizer determines a totalized amount when the flow rate of the first stream reaches the required amount based upon the measured flow rate and outputs the totalized amount to the empirical model, and the empirical model compares the required amount to the totalized amount and determines a transition endpoint. A method of rapidly transitioning the reactor system from one polyolefin product to another is also disclosed. | 2015-05-28 |
20150148507 | MONOMERS, POLYMERS AND ARTICLES CONTAINING THE SAME FROM SUGAR DERIVED COMPOUNDS - Disclosed herein are monomers formed by reacting a sugar derived compound(s) comprising a lactone and two hydroxyls with a compound(s) comprising an isocyanate and an acrylate or methacrylate. Polymers formed from such monomers, and articles formed from the polymers are also disclosed. | 2015-05-28 |
20150148508 | (METH) ACRYLIC RESIN COMPOSITION - A (meth)acrylic resin composition comprising not less than 99.5% by mass of (meth)acrylic resin composed of 80 to 100% by mass of a structural unit derived from methyl methacrylate and 0 to 20% by mass of a structural unit derived from acrylic acid ester, wherein a difference between YI4 and YI1 is not more than 3, in which the YI4 is a yellowness index at optical path length 200 mm of an article obtained by injection molding of the (meth)acrylic resin composition at a cylinder temperature of 280° C. and a molding cycle of 4 minutes, and the YI1 is a yellowness index at optical path length 200 mm of an article obtained by injection molding of the (meth)acrylic resin composition at a cylinder temperature of 280° C. and a molding cycle of 1 minute; and the (meth)acrylic resin composition has a melt flow rate under conditions of 230° C. and 3.8 kg load of not less than 25 g/10 min. | 2015-05-28 |
20150148509 | ALLYL GROUP-MODIFIED FLUOROOXYALKYLENE GROUP-CONTAINING POLYMER AND METHOD FOR PRODUCING THE SAME - The present invention provides an allyl group-modified fluorooxyalkylene group-containing polymer that is represented by the following general formula (1) and has a number average molecular weight of 1,000 to 50,000 in terms of polystyrene, | 2015-05-28 |
20150148510 | CURABLE COMPOSITIONS FOR LED ENCAPSULANTS COMPRISING A POLYCARBOSILANE AND A HYDROSILICONE - The present invention provides a curable composition, comprising: | 2015-05-28 |
20150148511 | Organopolysiloxane Polymers - Inventive organopolysiloxanes and consumer product compositions comprising such organopolysiloxanes. Such compositions can deposit effectively onto target substrates to deliver consumer-desired benefits such as conditioning, anti-wrinkle, softness, and anti-static. | 2015-05-28 |
20150148512 | NOVEL METHOD FOR PREPARING POLYTHIOL COMPOUND AND POLYMERIC COMPOSITION FOR OPTICAL MATERIAL COMPRISING SAME - The present invention relates to novel methods for preparing a polythiol compound for use in an optical material and polymerizable compositions including a polythiol compound prepared by the methods. According to the methods, a polythiol compound with uniform color, high purity and high quality can be prepared at reduced cost. The polymerizable compositions can be used to manufacture clear, transparent optical lenses with good heat resistance and excellent optical properties. | 2015-05-28 |
20150148513 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS - The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate, 1,4-butanediol, or other product pathway and being capable of producing 4-hydroxybutyrate, 1,4-butanediol, or other product, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate, 1,4-butanediol, or other product or related products using the microbial organisms. | 2015-05-28 |
20150148514 | METHOD FOR IDENTIFYING BIOABSORBABLE POLYMERS - A system and method for producing a bioabsorbable thermoplastic polyurethane tailored to a medical application are provided. The method includes identifying suitable thermoplastic polyurethane properties based on the medical application. The thermoplastic polyurethane comprises units derived from a diol chain extender, a diisocyanate, and a polyol. The thermoplastic polyurethane properties include a biodegradation rate and at least one physical property. The method includes identifying a base thermoplastic polyurethane and altering at least one parameter of the base thermoplastic polyurethane which relates to the desired thermoplastic polyurethane properties to generate a candidate thermoplastic polyurethane. The altering may be performed iteratively until the suitable range of thermoplastic polyurethane properties based on the medical application is met. | 2015-05-28 |
20150148515 | POLYESTER RESIN AND METHOD FOR PREPARING THE SAME - There is provided a polyester resin including: moieties of dicarboxylic acid components including terephthalic acid; and moieties of diol components including 5 to 60 mole % of isosorbide, 10 to 80 mole % of a cyclohexanedimethanol, and the balance of other diol compounds, wherein the polyester resin has an intrinsic viscosity of 0.5 to 1.0 dl/g and oxygen permeability of less than 20 cc*mm/(m | 2015-05-28 |
20150148516 | PROCESS FOR IMMORTAL RING-OPENING POLYMERISATION OF CYCLIC ESTERS AND CYCLIC CARBONATES - The present invention discloses new catalyst systems based on complexes of divalent metals supported by chelating phenoxy ligands for immortal ring-opening polymerisation of cyclic esters and cyclic carbonates. | 2015-05-28 |
20150148517 | NEW COMPOUND, POLY(IMIDE-AMIDE) COPOLYMER, AND AN ARTICLE INCLUDING THE POLY(IMIDE-AMIDE) COPOLYMER - A compound represented by Chemical Formula 1: | 2015-05-28 |
20150148518 | BRANCHED POLYAMIDE - The invention relates to a branched polyamide prepolymer obtained or obtainable by polymerization of a polyamide forming monomer mixture, comprising AA-BB repeat units and branching units derived from diamines (monomer A) dicarboxylic acids (monomer B), and/or a salt of A and B, and a higher functional monomer (monomer C) present in a molar amounts defined by formula I and formula II: MC=(Q/FC)*(MA+MB) (Formula I) and R=((MA*2)+(MC*FCA))/((MB*2)+(MC*FCB)) (Formula II) wherein—MA, MB and MC represent the molar amounts of repeat units derived from the monomers A, B and C, respectively;—FC represent the functionality of monomer C, and is equal to FC-A+FC-B;—FC-A is the number of the amino functional groups comprised by monomer C;—FC-B is the number of carboxyl functional groups or precursor groups thereof comprised by monomer C;—Q is a number in the range of 0.06-1.00; and—R is a number in the range of 0.7-1.3, which polyamide prepolymer has a viscosity number (VN), measured according to ISO 307, in the range of 7-30 mL/g. The invention also relates to a process for preparing a branched polyamide polymer, comprising (1) a melt-mixing step wherein an essentially linear polyamide (pre)polymer and a branched polyamide prepolymer are provided to and mixed and heated in a melt mixing apparatus, thereby forming a mixed melt, and the mixed melt being cooled, thereby forming a solid mixture; and (2) a solid state post condensation step wherein the solid mixture is post-condensed at elevated temperature in the solid state, thereby forming a high molecular weight branched polyamide polymer. | 2015-05-28 |
20150148519 | FLAME RETARDANT POLYMERS CONTAINING RENEWABLE CONTENT - A flame retardant polymer is prepared from renewable content. In an exemplary synthetic method, a bio-derived flame retardant polymer is prepared by a polycondensation reaction of a biobased diol (e.g., isosorbide) and a phosphorus-containing monomer (e.g., phenylphosphonic dichloride). The biobased diol may be obtained either directly from, or through modification of, a biological product. Preferably, at least 50% of the mass of the biobased diol is obtained directly from a biological product. The phosphorus-containing monomer may be a phosphonic dichloride, dichlorophosphate, alkyl/aryl phosphonate, or other phosphorus-containing monomer known for flame retardancy. | 2015-05-28 |
20150148520 | SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR - Single chain insulin analogs are provided having high potency and specificity for the insulin receptor. As disclosed herein optimally sized linking moieties can be used to link human insulin A and B chains, or analogs or derivatives thereof, wherein the carboxy terminus of the B25 amino acid of the B chain is linked to the amino terminus of the A1 amino acid of the A chain via the intervening linking moiety. In on embodiment the linking moiety comprises a polyethylene glycol of 6-16 monomer units and in an alternative embodiment the linking moiety comprises a non-native amino acid sequence derived form the IGF-1 C-peptide and comprising at least 8 amino acids and no more than 12 amino acid in length. Also disclosed are prodrug and conjugate derivatives of the single chain insulin analogs. | 2015-05-28 |
20150148521 | INSULINS WITH AN ACYL MOIETY COMPRISING REPEATING UNITS OF ALKYLENE GLYCOL CONTAINING AMINO ACIDS - Acylated insulins wherein an acyl moiety is attached to the parent insulin and wherein said acyl moiety comprises repeating units of alkylene glycol containing amino acids and wherein there is only one lysine residue (K & Lys) in the parent insulin have satisfactory properties when administered pulmonary. | 2015-05-28 |
20150148522 | SOMATOSTATIN-DOPAMINE CHIMERIC ANALOGS - The present invention relates to novel somatostatin-dopamine chimeric analogs and their therapeutic uses for the inhibition, prevention, and/or treatment of neoplasia, neuroendocrine tumors, Cushing's disease/syndrome, and other conditions. | 2015-05-28 |
20150148523 | GAMMA AMINO ACID BUILDING BLOCKS - The invention provides compounds and methods, for example, to carry out organocatalytic Michael additions of aldehydes to cyclically constrained nitroethylene compounds catalyzed by a proline derivative to provide cyclically constrained α-substituted-γ-nitro-aldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96 to >99% e.e.). | 2015-05-28 |
20150148524 | AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS - A method for the synthesis of an amino acid analogue or a salt, solvate, derivative, isomer or tautomer thereof comprising the steps of: (i) subjecting an amino acid containing a metathesisable group to metathesis with a compound containing a complementary metathesisable group of formula (I) or (II): (Formulae (I), (II)) wherein R | 2015-05-28 |
20150148525 | METHODS OF INCORPORATING AN AMINO ACID COMPRISING A BCN GROUP INTO A POLYPEPTIDE USING AN ORTHOGONAL CODON ENCODING IT AND AN ORTHORGONAL PYLRS SYNTHASE - The invention relates to a polypeptide comprising an amino acid having a bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) group, particularly when said BCN group is present as: a residue of a lysine amino acid. The invention also relates to a method of producing a polypeptide comprising a BCN group, said method comprising genetically incorporating an amino acid comprising a BCN group into a polypeptide. The invention also relates to an amino acid comprising bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN), particularly and amino acid which is bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) lysine. In addition the invention relates to a PylRS tRNA synthetase comprising the mutations Y271M, L274G and C313A. | 2015-05-28 |
20150148526 | METHODS FOR REDUCING LEVELS OF PROTEIN-CONTAMINANT COMPLEXES AND AGGREGATES IN PROTEIN PREPARATIONS BY TREATMENT WITH ELECTROPOSITIVE ORGANIC ADDITIVES - Methods for reduction of aggregate levels in antibody and other protein preparations through treatment with low concentrations of electropositive organic additives (e.g., ethacridine, chlorhexidine, or polyethylenimine) in combination with ureides (e.g., urea, uric acid, or allantoin) or organic modulators (e.g., nonionic organic polymers, surfactants, organic solvent or ureides). Some aspects of the invention relate to methods for reducing the level of aggregates in conjunction with clarification of cell culture harvest. It further relates to the integration of these capabilities with other purification methods to achieve the desired level of final purification. | 2015-05-28 |
20150148527 | SUGAR CHAIN-CONTAINING POLYMER, AND SUGAR CHAIN-CONTAINING POLYMER COMPLEX - A sugar chain-containing polymer that enables targeting to the lesion area of liver fibrosis and is useful for imaging, diagnosis and therapy of liver fibrosis; and a sugar chain-containing polymer complex comprising the polymer as a carrier for an anionic substance useful fix therapy and the like; are provided. The polymer is a sugar chain-containing polymer which is a cationic polymer comprising an amine, which polymer comprises N-acetylglucosamine bound thereto. The polymer preferably has a disulfide bond. The polymer preferably has a structure in which polyethyleneimine is linked via a disulfide bond. | 2015-05-28 |
20150148528 | CHROMATOGRAPHIC PURIFICATION OF POLYNUCLEOTIDES WITH NEGATIVELY CHARGED PARTICLES - A method of purifying a sample that includes a polynucleotide includes the steps of (i) providing a packed chromatographic column having negatively charged porous particles, (ii) equilibrating the column to the conditions to which the polynucleotide in the sample is to elute, (iii) contacting the sample with the packed chromatographic column such that the sample volume applied to the packed chromatographic column is less than or equal to the interparticle space of the negatively charged porous particles within the packed chromatographic column, (iv) eluting the polynucleotide from the packed chromatographic column, where the polynucleotide is in a purer state and in the conditions to which the packed chromatographic column was equilibrated. | 2015-05-28 |
20150148529 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID-POLYSACCHARIDE COMPLEX - As a means for solving the problem of providing a nucleic acid conjugate that does not undergo degradation at a DNA-RNA bonding site even in vivo, provided is a nucleic acid conjugate comprising a single-stranded DNA and a double-stranded RNA, wherein the 3′ position of the 3′-terminal deoxyribonucleotide residue of the single-stranded DNA is bonded to the 5′ position of the 5′-terminal ribonucleotide residue of one of the ribonucleotide strands of the double-stranded RNA, and the hydroxyl group at the 2′ position of the 5′-terminal nucleotide of the ribonucleotide strand, which is bonded to the single-stranded DNA, is substituted with an alkoxy group or a halogen atom, and/or the phosphate diester group between the 3′ position of the first ribonucleotide bonded to the single-stranded DNA and the 5′ position of the adjacent ribonucleotide is substituted with any of phosphorothioate group, dithiophosphate diester group and trithiophosphate diester group. | 2015-05-28 |
20150148530 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) - The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism. | 2015-05-28 |
20150148531 | METHOD FOR THE MANUFACTURE OF CARBONYL DERIVATIVES OF POLYSACCHARIDES - The invention relates to a method for the manufacture of carbonyl derivatives of polysaccharides and to the oxidization of polysaccharides in the presence of nitrogen dioxide to yield carbonyl derivatives of polysaccharides. The products including carbonyl derivatives of polysaccharides, obtained by the method are also described. | 2015-05-28 |
20150148532 | Methods for Biodegradable Derivatization of Cellulosic Surfaces - The present invention describes methods of treating cellulosic materials with a composition that provides increased hydrophobicity to such materials without sacrificing the biodegradability thereof. The methods as disclosed provide for esterification of available hydroxyl groups on cellulosic materials, where such hydroxyl groups are “masked” by bulky organic chains, including that the disclosure provides products made by such methods. The materials thus treated display higher hydrophobicity, barrier function, and mechanical properties, and may be used in any application where such features are desired. | 2015-05-28 |
20150148533 | New Synthetic Route For The Preparation Of Beta-aminobutyryl Substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]Pyrazin-7-yl Compounds - The present invention relates to a process for preparing □-aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-α]pyrazin-7-yl compounds. | 2015-05-28 |
20150148534 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYL TRANSFERASE INHIBITORS - Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis. | 2015-05-28 |
20150148535 | Method For Preparing Nitrogen Compounds - The present invention relates to a method for preparing nitrogen compounds using carbon dioxide, and to the use of the method in the production of vitamins, pharmaceutical products, adhesives, acrylic fibres, synthetic leathers, pesticides, herbicides, antifungal agents and fertilisers. The invention also relates to a method for producing vitamins, pharmaceutical products, adhesives, acrylic fibres, synthetic leathers, pesticides, herbicides, antifungal agents and fertilisers, which includes a step of preparing nitrogen compounds using the method of the invention. The invention further relates to a method for preparing labelled nitrogen compounds using carbon dioxide and to the uses thereof. | 2015-05-28 |
20150148536 | NEW BIS-IRIDIUM-COMPLEXES FOR MANUFACTURING OF ECL-LABELS - The present invention relates to novel bis-iridium-based Ir(III) complexes, labels manufactured using these complexes and a method for producing such complexes. | 2015-05-28 |
20150148537 | PROCESS FOR REDUCING CONTAMINATING MICHAEL ACCEPTOR LEVELS IN OXYCODONE AND OTHER COMPOSITIONS - The present invention relates to processes for removal of Michael acceptors from certain compositions wherein the composition is treated with a thiol-containing compound under conditions sufficient to remove Michael acceptors and the resulting thiol-Michael adducts. Certain embodiments of the present invention enable quantification and/or removal of Michael acceptors and/or Michael acceptor precursors. | 2015-05-28 |
20150148538 | USE OF AN H4 AGONIST MOLECULE TO TREAT ACUTE LEUKEMIA - The present invention relates to the use of new chemical substances, the levogyre and dextrogyre enantiomers of (AMINO-7 TRIETHOXY-4,5,6 OXO-1 DIHYDRO-1,3 ISOBENZOFURANNYL-3)-1 METHOXY-8 METHYL-2METHYLENEDIOXY-6,7 TETRAHYDRO-,2,3,4 ISOQUINOLEINE or tritoqualine, to treat acute myeloid or lymphoid leukemia, with the exception of type B leukemia. | 2015-05-28 |
20150148539 | Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof - The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial. | 2015-05-28 |
20150148541 | NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS - Provided herein are novel and selective high affinity α3β4 nicotinic acetycholine receptor ligands and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, drug addiction or pain using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of selectively antagonizing receptors such as, for example, the α3β4 nicotinic acetycholine receptor using the compounds and compositions disclosed herein. | 2015-05-28 |
20150148542 | METHOD FOR PREPARING SUBSTITUTED TRIAZOLOPYRIDINES - The present invention relates to methods of preparing substituted triazolopyridine compounds of general formula (I) as described and defined herein, as well as to intermediate compounds useful in the preparation of said compounds. | 2015-05-28 |
20150148543 | Methods and Compositions for the Synthesis of Multimerizing Agents - The invention features methods and compositions for the synthesis of multimerizing agents. | 2015-05-28 |
20150148544 | NOVEL REAGENTS AND METHOD FOR CONJUGATING BIOLOGICAL MOLECULES - A compound of the general formula X—[NR—CO—Ar—CO—(CH═CH) | 2015-05-28 |
20150148545 | PROTEIN TYROSINE PHOSPHATASE INHIBITOR, PREPARATION METHOD AND USES THEREOF - Disclosed in the present invention is a protein tyrosine phosphatase inhibitor. The preparation method therefor is: extracting the crude product from the | 2015-05-28 |
20150148546 | PHOTOSENSITIVE RESIN COMPOSITIONS, PROCESSES FOR PREPARING CURED FILMS, THE RESULTING CURED FILMS, ORGANIC EL DISPLAY DEVICES AND LIQUID CRYSTAL DISPLAY DEVICES - Provided is a photosensitive resin composition having high sensitivity and storage stability. The photosensitive resin composition comprises (A) a polymer component including a polymer satisfying at least one of (1) and (2) below: | 2015-05-28 |
20150148547 | (R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel - (R)-Nifuratel is disclosed together with its use as bactericide and bacteriostatic agent as well as the pharmaceutical compositions containing the same; (R)-nifuratel has been surprisingly found to possess a better antimicrobial profile than either nifuratel racemate or (S)-nifuratel. A new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel is also disclosed. | 2015-05-28 |
20150148548 | Silodosin Intermediate and Preparation Method Therefor - Disclosed are a silodosin intermediate and a preparation method thereof. The silodosin intermediate has the structure shown by the formula (A). X is hydrogen or bromide and R | 2015-05-28 |
20150148549 | DISPOSABLE WORLD-TO-CHIP INTERFACE FOR DIGITAL MICROFLUIDICS - The present disclosure sets forth incorporating microfluidic chips Interfaces for use with digital microfluidic processes. Methods and devices according to the present disclosure utilize compact, integrated platforms that interface with a chip upstream and downstream of the reaction, as well as between intermediate reaction steps if needed. In some embodiments these interfaces are automated, including automation of a multiple reagent process. Various reagent delivery systems and methods are also disclosed. | 2015-05-28 |
20150148550 | NOVEL COMPOUNDS AS CHLORIDE CHANNEL BLOCKING AGENT - Disclosed is a novel compound to function as a calcium-dependent chloride channel blocking agent. | 2015-05-28 |
20150148551 | GENISTEIN FOR REDUCING LEVELS OF STORAGE COMPOUNDS IN THE TREATMENT AND/OR PREVENTION OF LYSOSOMAL STORAGE DISEASES (LSDS) - The subject of the invention is genistein for use in non-enzymatic method of treatment and/or prevention of the lysosomal storage diseases (LSDs) i.e. diseases with the underlying defect in degradation and resulting accumulation of organic compounds in lysosomes, to reduce the level of storage of organic compounds by reducing the rate of efficiency of accumulating organic substances synthesis and/or by increasing the rate of efficiency of cellular deposits degradation. | 2015-05-28 |
20150148552 | 23-YNE-VITAMIN D3 DERIVATIVE - To provide a novel vitamin D | 2015-05-28 |
20150148553 | Hydrothermal Conversion of Biomass to Hydrocarbon Products - The conversion of biomass to hydrocarbon products such as transportation fuels, kerosene, diesel oil, fuel oil, chemical and refinery plant feeds. The instant process uses a hydrocarbon, oxygenated hydrocarbon, or synthesis gas co-feed and hot pressurized water to convert the biomass in a manner commonly referred to as hydrothermal liquefaction. | 2015-05-28 |
20150148554 | PROCESS FOR PREPARING BIODEGRADABLE LUBRICANT BASE OILS - The invention discloses an improved process for preparing fatty acid esters with 100 mol % selectivity suitable as biodegradable lubricant base oils, comprising contacting a fatty compound with an alcohol in presence of a solid, phosphonate catalyst having molecular formula: M(X)2-nYn.mH2O where X refers to phenyl phosphonate, Y refers to HPO42− or HPO32−, M refers to a metal or metalloid ion preferably taken from the group consisting of Zr, Zn, Cd, Al, Sn, La and Ce, the value of n varies from 0.2 to 1.8 and the value of m varies from 0 to 5, wherein the fatty compound is a fatty acid or fatty acid methyl or ethyl ester or vegetable oil or animal fat or their mixture thereof and alcohol is a monohydric alcohol with 6 to 22 carbon atoms or a polyol with at least two hydroxyl groups. | 2015-05-28 |
20150148555 | Method for Solubilising and Separating One or a Plurality of Carboxylic Acids and Use of a Demobilised Solubilising Compound - A method for solubilising and separating one or a plurality of carboxylic acids or carboxylic acid derivatives from an aqueous or organic solution, emulsion or suspension, involves (i) preparing the solution or emulsion or suspension with the carboxylic acid or the carboxylic acid derivatives; (ii) adding a quantity of a solubilising compound, in particular arginine or an arginine derivative, to the solution, suspension or emulsion in the presence of a minimum amount of water, a demobilised solubilising compound being used as a solubilising compound; (iii) separating the solubilised carboxylic acids or carboxylic acid derivatives as a carboxylic acid phase or carboxylic acid derivative phase from the solution or emulsion or suspension; and (iv) preferably regaining at least one portion of the solubilising compound or one portion of a derivative of the solubilising compound, in particular of the arginine or the arginine derivative, from the solubilised and separated carboxylic acid phase or carboxylic acid derivative phase. | 2015-05-28 |
20150148556 | PROCESS FOR STABILIZING HYDROCYANATION CATALYST - The invention provides a method of forming a phosphonate diester compound from a ligand hydrolysis product (LHP) of a phosphite ligand used in a nickel-phosphite hydrocyanation catalyst, such as for conversion of 3-pentenenitrile to adiponitrile, which serves to climinate acidic LHP compound for a hydrocyanation reaction milieu where the acidic LHP can catalyze further catalyst ligand destruction. The invention further provides phosphonate disester compounds prepared by alkylation of diarylphosphite LHP in the presence of a nickel-phosphite catalyst comprising a bidentate ligand, and a continuous hydrocyanation process for production of adiponitrile wherein catalyst ligand breakdown is inhibited through inactivation of ligand hydrolysis products towards further breakdown. A method of stabilizing a hydrocyanation catalyst is provided. | 2015-05-28 |
20150148557 | MOLECULAR LAYER DEPOSITION USING REDUCTION PROCESS - A material is deposited onto a substrate by exposing the substrate to a metal-containing precursor to adsorb metal atoms of the metal-containing precursor to the substrate. The substrate injected with the metal-containing precursor is exposed to an organic precursor to deposit a layer of material by a reaction of the organic precursor with the metal atoms adsorbed to the substrate. The substrate is exposed to radicals of a reducing agent to increase reactivity of the material deposited on the substrate. The radicals of the reducing agent are produced by applying a voltage differential with electrodes to a gas such as hydrogen. The substrate may be exposed to radicals before and/or after exposing the substrate to the organic precursor. The substrate may be sequentially exposed to two or more different organic precursors. The material deposited on the substrate may be a metalcone such as Alucone, Zincone, Zircone, Titanicone, or Nickelcone. | 2015-05-28 |
20150148558 | METHOD FOR PRODUCING NITRILE - The present invention provides a method for producing a nitrile represented by general formula (1) (in the formula, R denotes an optionally substituted alkyl group, alkenyl group, dienyl group, aralkyl group or aryl group having a total of 3-20 carbon atoms), and the method includes heating an aldoxime represented by general formula (2) (in the formula, R denotes the same groups as those mentioned above) at 80-250° C. in the presence of an alkali metal or alkaline earth metal salt of phosphoric acid (catalyst A) and distilling off water generated as the reaction progresses to outside the reaction system. | 2015-05-28 |
20150148559 | PROCESS FOR MAKING AMINO ACID COMPOUNDS - The invention provides new processes for making and purifying amino acid compounds, which are useful in the preparation of AKT inhibitors used in the treatment of diseases such as cancer, including the compound (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one. | 2015-05-28 |
20150148560 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF - Provided herein are methods that utilize polyhydroxyalkanoates (PHAs) as a substrate for further conversion to C4 and C5 compounds. Polyhydroxyalkanoates can undergo esterification to yield alkyl hydroxyalkanoates and alkyl alkenoates, which may serve as useful precursors in the production of alkadienes and alkenedioic acids, including for example butadiene and butenedioic acid. | 2015-05-28 |
20150148561 | LINEAR ALKYLBENZENES FROM NATURAL OILS AND METHODS OF PRODUCING - A linear alkyl benzene product and production of linear alkylbenzene from a natural oil are provided. A method comprises the step of deoxygenating the natural oils to form a stream comprising paraffins. The paraffins are dehydrogenated to provide mono-olefins. Then, benzene is alkylated with the mono-olefins under alkylation conditions to provide an alkylation effluent comprising alkylbenzenes and benzene. Thereafter, the alkylbenzenes are isolated to provide the alkylbenzene product. | 2015-05-28 |
20150148562 | Removal of Aromatics from Carbonylation Process - The invention relates to processes for removing aromatics from the reactants that are fed to a carbonylation reactor. The aromatics are removed using a guard bed that comprises an adsorbent. | 2015-05-28 |
20150148563 | Catalyst Material for the Oxidation of Hydrocarbons - A catalyst material for the oxidation and/or oxidative dehydrogenation of hydrocarbons, in particular for the selective oxidation of propane to acrylic acid, is specified, comprising a) molybdenum (Mo), b) vanadium (V), c) niobium (Nb), d) tellurium (Te), e) nickel (Ni), f) tungsten (W) and g) manganese (Mn), in which the molar ratio of at least one element, which is selected from nickel, tungsten and manganese, to molybdenum lies in the range 0.01 to 0.2, more preferably 0.05 to 0.15 and particularly preferably from 0.0025:1 to 0.3:1. Furthermore, a catalyst for the oxidation and/or oxidative dehydrogenation of hydrocarbons, a use of the catalyst material or of the catalyst, a method for producing a catalyst material for the oxidation and/or oxidative dehydrogenation of hydrocarbons and a method for the selective oxidation of propane to acrylic acid is specified. | 2015-05-28 |
20150148564 | PROCESS FOR PREPARING 2,2-DIBROMOMALONAMIDE - The present invention generally relates to a process for preparing 2,2-dibromomalonamide from 2,2-dibromo-3-cyanoacetamide. | 2015-05-28 |
20150148565 | Method of Forming Alkoxylated Fluoroalcohols - A method of forming an alkoxylated fluoroalcohol is accomplished by providing a boron compound having or providing at least one boron-oxygen bond and an iodine source. The boron compound and iodine source are combined with reactants of a fluoroalcohol and an alkylene oxide in the presence of a base. The reactants are allowed to react to form an alkoxylated fluoroalcohol reaction product. | 2015-05-28 |
20150148566 | PHENOLIC RESIN PRECURSORS VIA SUPERCRITICAL WATER - A method for transforming selected plant or plant-derived materials, and optionally selected waste plastics, into a plurality of phenolic reaction products having a lower sulphur content than the original feedstock, via supercritical water is disclosed. The method comprises: conveying the selected plant or plant-derived materials, and optionally waste plastic material, through an extruder, wherein the extruder is configured to continuously convey the selected feedstock to a supercritical fluid reaction zone; injecting hot compressed water into the supercritical fluid reaction zone, while the extruder is conveying the selected plant and/or plant-derived mixture and optionally waste plastic material into the supercritical fluid reaction zone so as to yield a water-containing mixture; retaining the mixture within the reaction zone for a period of time sufficient to yield the plurality of phenolic reaction products having a lower sulphur content than the original feedstock. The reaction zone may be characterized by a tubular reactor having an adjustably positionable inner tubular spear, wherein the tubular reactor and the inner tubular spear further define an annular space within the reaction zone, and wherein the mixture flows through the annular space and into a reaction products chamber for separation into three phases. | 2015-05-28 |
20150148567 | MIXED METAL OXIDE CATALYSTS AND USE THEREOF - Disclosed herein are catalyst compositions useful in selective decomposition of organic oxygenates. A feed comprising an organic oxygenate may be contacted with a catalyst comprising (a) at least 0.1 wt % of an oxide of an element selected from Group 3 of the Periodic Table of Elements, wherein Group 3 includes the Lanthanide series; (b) at least 0.1 wt % of an oxide of an element selected from Group 6 of the Periodic Table of Elements; and (c) at least 0.1 wt % of an oxide of at least one element selected from Group 4 of the Periodic Table of Elements, wherein the wt % s are based upon the total combined weight of the oxides in (a) through (c) and excludes any other components. | 2015-05-28 |
20150148568 | PROCESS FOR PRODUCING PHENOL - In a process for producing phenol, benzene is contacted with a C3 alkylating agent comprising isopropanol under alkylation conditions such that at least part of the isopropanol reacts with the benzene to produce cumene. At least part of the resultant cumene is then oxidized in the presence of an oxidizing gas to produce an oxidation effluent comprising cumene hydroperoxide, unreacted cumene and a spent oxidizing gas. The unreacted cumene is separated from the oxidation effluent and is treated to remove nitrogenous impurities therefrom and produce a purified cumene stream, which is recycled to the oxidization step. At least part of the cumene hydroperoxide from the oxidation effluent is cleaved to produce a cleavage effluent comprising phenol and acetone. The phenol is recovered phenol from the cleavage effluent, whereas at least part of the acetone from the cleavage effluent is hydrogenated to produce isopropanol for recycle to the alkylation step. | 2015-05-28 |
20150148569 | METHOD FOR OBTAINING HIGH ALCOHOLS - The present invention relates to a process for obtaining metal oxide catalysts comprising gallium which are capable of synthesising higher alcohols from lower alcohols. The process for obtaining said catalysts is also disclosed. | 2015-05-28 |
20150148570 | INTEGRATED PROCESS FOR THE PRODUCTION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE - The present invention is directed to processes for the production of 1233zd from 240fa and HF, with or without a catalyst, at a commercial scale. The 240fa and HF are fed to a reactor operating at high pressure. The resulting product stream comprising 1233zd, HCl, HF, and other byproducts is treated to one or more purification techniques including phase separation and one or more distillations to provide purified 1233zd, which meets commercial product specifications, i.e., having a GC purity of 99.5% or greater. | 2015-05-28 |
20150148571 | PROCESS FOR PRODUCING FLUORINE-CONTAINING OLEFIN - The present invention provides a process for producing a fluoroolefin by reacting, in a gas phase, a fluorinating agent and a chlorine-containing alkene or a chlorine-containing alkane in the presence of at least one catalyst selected from the group consisting of chromium oxide, at least part of which is crystallized, and fluorinated chromium oxide obtained by fluorinating the chromium oxide. According to the present process, a target fluoroolefin can be obtained at a high conversion rate of the starting material and with high selectivity. | 2015-05-28 |
20150148572 | Process for the Dimerization/Oligomerization of Mixed Butenes Over an Ion-Exchange Resin Catalyst - Processes for the effective dimerization and oligomerization of a mixed butenes feed using an ion exchange resin based catalyst are provided. The dimerization and oligomerization processes produce highly branched C8 and C8+ olefins (e.g., C12, C16 and C20 olefins) which could be used as superior fuel blending component for higher energy contents, higher octane value, higher octane sensitivity and lower RVP. | 2015-05-28 |
20150148573 | OLIGOMERISATION OF OLEFINS FOR THE PRODUCTION OF SYNTHETIC FUEL - The invention relates to a synthetic hydrocarbon fuel composition, and a process for making such a fuel composition, in which the fuel composition has the following properties:
| 2015-05-28 |
20150148574 | PROCESS FOR THE PREPARATION OF AN OLEFIN PRODUCT - A process for the preparation of an olefin product, which process comprises the steps of: a) converting an oxygenate feedstock in an oxygenate-to-olefins conversion system, comprising a reaction zone in which an oxygenate feedstock is contacted with an oxygenate conversion catalyst under oxygenate conversion conditions, to obtain a conversion effluent comprising olefins and paraffins; b) separating at least a portion of the paraffins from the conversion effluent to form a paraffin stream; and c) recycling at least a portion of the paraffin stream to step a). | 2015-05-28 |
20150148575 | INCREASED CONVERSION OF RECYCLED OXYGENATES IN MTO - A process is presented for increasing the conversion efficiency of oxygenates to olefins. The conversion of oxygenates recycles unconverted oxygenates and oxygenate by-products to a second reactor unit. The present of oxygenate by-products decreases the efficiency of the methanol to olefins reaction, and passing recycled oxygenates to a second reactor unit maintains the methanol to olefins conversion efficiency while converting the by-products in a secondary zone. | 2015-05-28 |
20150148576 | SEPARATION OF ISO-OLEFINS FROM PARAFFINS IN THE C15 TO C18 RANGE - A process is presented for the separation of iso-olefins from a hydrocarbon mixture comprising paraffins and olefins. The process includes an adsorption separation system, wherein the adsorbent is selected according to the properties of the material that is desired to be adsorbed. The process also includes a selection of a desorbent, which can comprise a mixture, to provide for an enhanced recovery of the adsorbed material and a separation of the iso-olefins from paraffins. | 2015-05-28 |
20150148577 | SEPARATION OF ISO-OLEFINS FROM PARAFFINS IN THE C19 TO C22 RANGE - A process is presented for the separation of iso-olefins from a hydrocarbon mixture comprising paraffins and olefins. The process includes an adsorption separation system, wherein the adsorbent is selected according to the properties of the material that is desired to be adsorbed. The process also includes a selection of a desorbent, which can comprise a mixture, to provide for an enhanced recovery of the adsorbed material and a separation of the iso-olefins from paraffins. | 2015-05-28 |
20150148578 | Unsupported Metal Substituted Heteropolyacid Catalysts For Dimerization And/Or Oligomerization of Olefins - The present invention relates to unsupported metal (e.g., cesium) substituted heteropolyacid catalyst compositions useful for the production of butene dimers and/or oligomers from a mixed butenes feed, in which, under mild conditions, all isomers of mixed butenes produce highly branched C8 and C8+ olefins, useful as octane enhancers. | 2015-05-28 |
20150148579 | METHOD FOR MAKING A CATALYST COMPRISING A PHOSPHORUS MODIFIED ZEOLITE TO BE USED IN A MTO PROCESS - The present invention is the use of a catalyst in a MTO process to convert an alcohol or an ether into light olefins wherein said catalyst comprises a phosphorus modified zeolite and is made by a method comprising the following steps in this order, | 2015-05-28 |
20150148580 | METHOD FOR PRODUCING OLEFIN - Disclosed are a catalyst for producing, from an alcohol, an olefin whose number of carbon atoms is at least one more than the number of carbon atoms of the alcohol, wherein at least the surface of the catalyst is substantially composed of zirconium oxide; a method for producing an olefin using the same; and so on. | 2015-05-28 |
20150148581 | METHODS FOR PREPARING COMPOSITES OF ACTIVATED CARBON/ZINC OXIDE AND ACTIVATED CARBON/ZINC OXIDE/NICKEL OXIDE FOR DESULFURIZATION OF FUELS - Activated carbon\nickel oxide\zinc oxide (AC\NiO\ZnO) and activated carbon\zinc oxide (AC\ZnO) were prepared and used as adsorbents for removal of thiophene, benzothiophene (BT) and dibenzothiophene (DBT) as sulfur compounds from hydrocarbon materials such as diesel fuel. The materials exhibited an efficient and economical way for removing sulfur compounds due to its low-energy consumption, ambient operation temperature and atmospheric pressure. A simple regeneration method of the spent adsorbents. | 2015-05-28 |
20150148582 | METHOD FOR REMOVING THE 137Cs FROM POLLUTED EAF DUSTS - The present invention refers to a method and related plants for removing, by means of redox reactions, the | 2015-05-28 |
20150148583 | METHOD OF DETOXIFYING ASBESTOS BY USING ROOM-TEMPERATURE RECRYSTALLIZATION SCHEME - Disclosed is a method of detoxifying asbestos by using a room-temperature recrystallization scheme. The method includes heat-treating a rock or slate containing asbestos; and putting the heat-treated rock or slate in an aqueous solution, to which organic acid is added, to allow the heat-treated rock or slate to react with the aqueous solution having the organic acid. | 2015-05-28 |
20150148584 | INNER GANTRY - A system includes a patient support and an outer gantry on which an accelerator is mounted to enable the accelerator to move through a range of positions around a patient on the patient support. The accelerator is configured to produce a proton or ion beam having an energy level sufficient to reach a target in the patient. An inner gantry includes an aperture for directing the proton or ion beam towards the target. | 2015-05-28 |
20150148585 | COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA - This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic. | 2015-05-28 |
20150148586 | CONTENT OUTPUT DEVICE, CONTENT OUTPUT METHOD, CONTROL DEVICE, AND CONTROL METHOD - There is provided a content output device including a selection unit which selects content according to a user's condition and a magnetic field pattern corresponding to the content, a content output unit which outputs the content, and a magnetic field generating unit which generates a magnetic field based on the magnetic field pattern. | 2015-05-28 |
20150148587 | Generating Artificial Pulse - In order to produce a pulsatile blood flow pattern that includes time periods of relatively high blood flow rates and time periods of relatively low blood flow rates, the operating speed of a blood pump can be selectively controlled to produce an operating speed pattern that includes time periods of relatively high rotation speeds and periods of relatively low rotation speeds. For example, the blood pump is rotated at a first speed for a first period of time. The speed of the blood pump is then decreased from the first speed to a second speed and is operated at the second speed for a second amount of time. The speed of the blood pump is then decreased to a third speed for a third amount of time. If desired, the operating speed pattern can be repeated to continue the pulsatile blood flow pattern. | 2015-05-28 |
20150148588 | METHOD OF REMOVING AN INFLATED IMPLANT FROM A BLADDER - An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways. | 2015-05-28 |
20150148590 | SYSTEM FOR TREATING HEART VALVE MALFUNCTION INCLUDING MITRAL REGURGITATION - A system for treating heart valve malfunction specifically including mitral regurgitation comprising a positioning structure operative to assume both expanded and contracted orientations and a retaining assembly positioned and structured to operatively dispose the positioning structure in moveably supporting lifting and/or positioning relation to the ventricular wall portion of the heart. The retaining assembly and the positioning structure are cooperatively disposed and structured to accomplish a shape variance of the heart upon a lifting or positioning force being exerted thereon substantially concurrent to the positioning structure being disposed in the expanded orientation. The force exerted on the heart at least partially defines a shape variance thereof to the extent of positioning of the leaflets of the mitral valve into a closed orientation which restricts mitral regurgitation. | 2015-05-28 |
20150148591 | INCONTINENCE IMPLANT, INSERTION DEVICE AND RELATED METHODS OF USE - The present invention discloses medical systems and related methods of use. One such medical system includes an implant assembly and an insertion device. The insertion device includes an elongate member and a hub member. The elongate member includes a needle portion and a handle portion. The hub member is movably coupled to the handle portion of the elongate member. The hub member is configured to be removably coupled to the implant assembly. | 2015-05-28 |
20150148593 | MEDICAL SCOPE ATTACHMENT DEVICE AND SYSTEM - A medical scope attachment device and system includes one or more expandable rings, each having a resilient main body and an inside diameter defining a central opening that corresponds to a dimension of a medical scope. One or more sets of opposing magnetic elements are disposed within each of the rings. The system also includes a ring attachment device having a shelf that is interposed between a pair of opposing electromagnets. The ring attachment device functioning to transition the expandable rings between an expanded and non-expanded state to receive an existing medical scope. | 2015-05-28 |
20150148594 | ENDOSCOPE OPERATION SYSTEM - The objective is to control a movement velocity of an endoscope in a body in response to an amount of insertion of the endoscope in view of safety without influence of a strong magnet. A velocity-control computation section | 2015-05-28 |
20150148595 | Method of Placing a Drainage Catheter System - The present disclosure describes a single incision method of placing a drainage catheter in the peritoneal cavity. | 2015-05-28 |
20150148596 | Surgical Instrument - A surgical instrument ( | 2015-05-28 |
20150148597 | SYSTEMS, DEVICES, AND METHODS FOR TISSUE EXTRACTION - Medical devices, systems, and related methods of use are disclosed. The systems may comprise a sheath for insertion into a body lumen and an extraction tool for passage through the sheath, wherein the extraction tool may include a handle, an end effector, and an optical device. Methods disclosed herein include introducing an extraction tool into a urethra for retrieving and removing tissue from the body, e.g., with an end effector, without morcellating the excised tissue. | 2015-05-28 |
20150148598 | WIRE DRIVER FOR WIRE LINE AND ENDOSCOPE - A side-viewing endoscope includes an elongated tube for entry in a body cavity for imaging. A wire line is contained in the elongated tube, for moving in an axial direction back and forth. A guide device is coupled with a distal end of the wire line, caused to shift between first and second positions by the wire line, for orientation in a direction crosswise to the axial direction upon being set in the second position. An input lever is disposed at a proximal end of the wire line, for moving the wire line in the axial direction. A cam mechanism is connected between the input lever and the wire line, for shifting the guide device at a first shift between the first position and an intermediate position, and shifting the guide device at a second shift smaller than the first shift between the intermediate and second positions. | 2015-05-28 |
20150148599 | CAPSULE ENDOSCOPIC DOCKING SYSTEM - A capsule endoscopic system is disclosed, wherein the system comprises a capsule endoscope, a docking station, second circuits and contact means to cause the second circuits connected to first circuits inside the capsule endoscope when the capsule endoscope is docked in the docking station in a first rotational orientation and in a second rotational orientation. The capsule endoscope comprises a capsule housing, the first circuits, and first contacts disposed fixedly on or through the capsule housing, wherein the first contacts are connected to the first circuits. The docking station comprises one or more second contacts. The docking station also includes a docking bay to receive the capsule endoscope. The second contacts are configured to contact the first contacts and to cause the first circuits to connect to the second circuits when the capsule endoscope is docked in the first rotational orientation and the second rotational orientation. | 2015-05-28 |
20150148600 | MEDICAL INSTRUMENT - The present invention provides a medical instrument which is capable of reducing damage, such as cutting of a wire, to the medical instrument even if excessively large load is applied to an inserting portion. A medical instrument including: a deformable portion; a wire configured to deform the deformable portion; a driving unit configured to drive the wire; a drive control unit configured to control the driving unit; and a load detecting unit configured to detect load applied to the deformable portion, wherein when the load detected by the load detecting unit exceeds a threshold value, the drive control unit controls the driving unit to retain posture of the deformable portion. | 2015-05-28 |
20150148601 | CATHETERS WITH INDENTED MARKERS - A catheter may include an elongate tubular member having an outer wall and an inner wall defining a wall thickness. The inner wall may define a lumen extending therethrough. The elongate tubular member may include a first plurality of recessed portions disposed in a distal section, wherein the first plurality of recessed portions each includes a visual marker disposed therein. | 2015-05-28 |
20150148602 | STEERING TECHNIQUES FOR SURGICAL INSTRUMENTS - A steerable endoscopic tool uses concentric sleeves of varying curvature to steer a tool tip toward or in the direction of a location of surgical interest. By rotating and/or axially displacing such sleeves relative to one another the tool tip may be maneuvered within a current field of view with several degrees of freedom without any physical movement of an endoscope, thus facilitating improved surgical access and control without complex mechanical systems in the endoscope or at the surgical site. | 2015-05-28 |
20150148603 | Imaging Catheter with Thermal Management Assembly - An imaging catheter assembly that includes an elongate body having a first body end, and an opposite second body end; an imaging assembly secured to the first body end, the imaging assembly having a first imaging assembly end remote from the first body end and a second imaging assembly end adjacent the first body end, the imaging assembly including a flex circuit having an electronic component mounting portion, a camera mounting portion adjacent the first imaging assembly end, and a light mounting portion adjacent the first imaging assembly end; a camera mounted on the camera mounting portion, the camera having a field of view, a light source mounted on the light mounting portion for illuminating at least a portion of the field of view of the camera; and at least one temperature sensor mounted on the flex circuit for measuring a temperature of the light source and a temperature of an ambient environment of the imaging assembly; and a control circuit in communication with the light source and the at least one temperature sensor, the control circuit controlling an output of the light source to control a difference between the temperature of the ambient environment and the temperature of the light source. The control circuit controls the difference between the temperature of the ambient environment and the temperature of the illumination source to a predetermined amount. | 2015-05-28 |
20150148604 | METHODS OF PROCESSING DATA OBTAINED FROM MEDICAL DEVICE - Computerized information processing methods for processing data from a medical device, such as an ingestible probe. In one embodiment, the method includes processing data obtained by the probe so as to produce a plurality of image frames, and further processing the frames to identify a plurality of frames of potential interest to a reviewer, and using the identified frames to form a preview of the entire data set. In one implementation, the processing of the data includes identification of one or more artifacts or shapes within the data associated with a medical condition, and selection of the frames for the preview includes those frames with the identified artifacts or shapes. | 2015-05-28 |
20150148605 | SYSTEM FOR USE IN SURGICAL PROCEDURES - A system and method for use in surgical procedures. The system includes an endoscope, an imaging device coupled to the endoscope, an imaging processor coupled to the imaging device, and at least one management system coupled to the imaging processor, in which a function of the management system is automatically adjusted upon receipt of a communication from the imaging processor. | 2015-05-28 |
20150148606 | ENDOSCOPIC SLEEVE - An endoscopic sleeve includes a tubular member from which spaced projecting elements. The projecting elements are bendable towards both proximal and distal directions of the tubular member. The force (insertion force) required to bend the projecting elements towards the proximal direction is less than a force (extraction force) required to bend the projecting elements towards the distal direction. An outer periphery of the projecting elements decreases as the extraction force increases. | 2015-05-28 |
20150148607 | DRIVING FORCE TRANSMITTING UNIT, INSERTION INSTRUMENT, ROTARY UNIT, INSERTION BODY ASSEMBLY, AND INSERTION DEVICE - A driving force transmitting unit includes a line portion extending along a driving axis in a channel, and a slider portion attached to a proximal portion of the line portion and movable relative to the line portion along the driving axis. The driving force transmitting unit includes an urging portion contracting in response to a movement of the slider portion relative to the line portion toward a distal direction and thereby applying an urging force toward the distal direction to the line portion. | 2015-05-28 |
20150148608 | SWITCHING VALVE UNIT AND ENDOSCOPE APPARATUS - In an endoscope apparatus, a suction button unit (switching valve unit) includes a valve cylinder, a piston rod, a cap device and seal packing. Holes are formed in a piston chamber of the valve cylinder, including a discharge port hole, a suction port hole and an exhaust port hole. The piston chamber includes a piston slide surface and a sliding sealing surface. A passage in the piston rod connects the exhaust port hole with the suction port hole in case the piston rod is in a halfway position, and connects the suction port hole with the discharge port hole in case the piston rod is in a position of full depression. The seal packing, in the halfway position, closes the discharge port hole, and in the position of full depression, causes the discharge port hole to open. Thus, operability and washability of the suction button unit can be high. | 2015-05-28 |